Insulin Market Size, Share & Trends Analysis Report By Product (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilar), By Application, By Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Segment Definitions
                       1.2.1. Product
                       1.2.2. Type
                       1.2.3. Application
                       1.2.4. Distribution Channel
                       1.2.5. Regional Scope
                       1.2.6. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Regional outlook
                   2.4. Competitive Insights
Chapter 3. Insulin Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Increase in prevalence of diabetes
                           3.2.1.2. Increase in geriatric and obese population
                           3.2.1.3. Formulation advancements in insulin delivery systems
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. High cost of insulin
                           3.2.2.2. Poor reimbursement policies
                           3.2.2.3. Launch of insulin biosimilars and increasing penetration of glp-1 agonists
                   3.3. Insulin Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Bargaining power of suppliers
                           3.3.1.2. Bargaining power of buyers
                           3.3.1.3. Threat of substitutes
                           3.3.1.4. Threat of new entrants
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Economic landscape
                           3.3.2.3. Social landscape
                           3.3.2.4. Technological landscape
                           3.3.2.5. Environmental landscape
                           3.3.2.6. Legal landscape
                   3.4. Pipeline & Opportunity Analysis
                       3.4.1. Efsitora alfa market estimates and forecasts to 2030 (USD million)
                       3.4.2. Icodec market estimates and forecasts to 2030 (USD million)
                       3.4.2. IcoSema market estimates and forecasts to 2030 (USD million)
                       3.4.4. Insulin Glargine Biosimilars market estimates and forecasts to 2030 (USD million)
                       3.4.5. Other phase III pipeline drugs market estimates and forecasts to 2030 (USD million)
Chapter 4. Insulin Market: Product Estimates & Trend Analysis
                   4.1. Segment Dashboard
                   4.2. Insulin Market: Product Movement Analysis
                   4.3. Insulin Market by Product Outlook (USD Million)
                   4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   4.5. Rapid-Acting Insulin
                       4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.6. Long-Acting Insulin
                       4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.7. Combination Insulin
                       4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.8. Biosimilar
                       4.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.9. Others
                       4.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Insulin Market: Type Estimates & Trend Analysis
                   5.1. Segment Dashboard
                   5.2. Insulin Market: Type Movement Analysis
                   5.3. Insulin Market by Type Outlook (USD Million)
                   5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   5.5. Human Insulin
                       5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   5.6. Insulin Analog
                       5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Insulin Market: Application Estimates & Trend Analysis
                   6.1. Segment Dashboard
                   6.2. Insulin Market: Application Movement Analysis
                   6.3. Insulin Market by Application Outlook (USD Million)
                   6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   6.5. Type 1 Diabetes Mellitus
                       6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   6.6. Type 2 Diabetes Mellitus
                       6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Insulin Market: Distribution Channel Estimates & Trend Analysis
                   7.1. Segment Dashboard
                   7.2. Insulin Market: Distribution Channel Movement Analysis
                   7.3. Insulin Market by Distribution Channel Outlook (USD Million)
                   7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   7.5. Hospitals
                       7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   7.6. Retail Pharmacies
                       7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                   7.7. Others
                       7.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Insulin Market: Regional Estimates & Trend Analysis
                   8.1. Regional Dashboard
                   8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
                   8.3. North America
                       8.3.1. U.S.
                           8.3.1.1. Key country dynamics
                           8.3.1.2. Regulatory framework/ reimbursement structure
                           8.3.1.3. Competitive scenario
                           8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                       8.3.2. Canada
                           8.3.2.1. Key country dynamics
                           8.3.2.2. Regulatory framework/ reimbursement structure
                           8.3.2.3. Competitive scenario
                           8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                       8.3.3. Mexico
                           8.3.3.1. Key country dynamics
                           8.3.3.2. Regulatory framework/ reimbursement structure
                           8.3.3.3. Competitive scenario
                           8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                   8.4. Europe
                       8.4.1. UK
                           8.4.1.1. Key country dynamics
                           8.4.1.2. Regulatory framework/ reimbursement structure
                           8.4.1.3. Competitive scenario
                           8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                       8.4.2. Germany
                           8.4.2.1. Key country dynamics
                           8.4.2.2. Regulatory framework/ reimbursement structure
                           8.4.2.3. Competitive scenario
                           8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                       8.4.3. France
                           8.4.3.1. Key country dynamics
                           8.4.3.2. Regulatory framework/ reimbursement structure
                           8.4.3.3. Competitive scenario
                           8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                       8.4.4. Italy
                           8.4.4.1. Key country dynamics
                           8.4.4.2. Regulatory framework/ reimbursement structure
                           8.4.4.3. Competitive scenario
                           8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                       8.4.5. Spain
                           8.4.5.1. Key country dynamics
                           8.4.5.2. Regulatory framework/ reimbursement structure
                           8.4.5.3. Competitive scenario
                           8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                       8.4.6. Norway
                           8.4.6.1. Key country dynamics
                           8.4.6.2. Regulatory framework/ reimbursement structure
                           8.4.6.3. Competitive scenario
                           8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                       8.4.7. Sweden
                           8.4.7.1. Key country dynamics
                           8.4.7.2. Regulatory framework/ reimbursement structure
                           8.4.7.3. Competitive scenario
                           8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                       8.4.8. Denmark
                           8.4.8.1. Key country dynamics
                           8.4.8.2. Regulatory framework/ reimbursement structure
                           8.4.8.3. Competitive scenario
                           8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                   8.5. Asia Pacific
                       8.5.1. Japan
                           8.5.1.1. Key country dynamics
                           8.5.1.2. Regulatory framework/ reimbursement structure
                           8.5.1.3. Competitive scenario
                           8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                       8.5.2. China
                           8.5.2.1. Key country dynamics
                           8.5.2.2. Regulatory framework/ reimbursement structure
                           8.5.2.3. Competitive scenario
                           8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                       8.5.3. India
                           8.5.3.1. Key country dynamics
                           8.5.3.2. Regulatory framework/ reimbursement structure
                           8.5.3.3. Competitive scenario
                           8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                       8.5.4. Australia
                           8.5.4.1. Key country dynamics
                           8.5.4.2. Regulatory framework/ reimbursement structure
                           8.5.4.3. Competitive scenario
                           8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                       8.5.5. South Korea
                           8.5.5.1. Key country dynamics
                           8.5.5.2. Regulatory framework/ reimbursement structure
                           8.5.5.3. Competitive scenario
                           8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                       8.5.6. Thailand
                           8.5.6.1. Key country dynamics
                           8.5.6.2. Regulatory framework/ reimbursement structure
                           8.5.6.3. Competitive scenario
                           8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                   8.6. Latin America
                       8.6.1. Brazil
                           8.6.1.1. Key country dynamics
                           8.6.1.2. Regulatory framework/ reimbursement structure
                           8.6.1.3. Competitive scenario
                           8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                       8.6.2. Argentina
                           8.6.2.1. Key country dynamics
                           8.6.2.2. Regulatory framework/ reimbursement structure
                           8.6.2.3. Competitive scenario
                           8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                   8.7. MEA
                       8.7.1. South Africa
                           8.7.1.1. Key country dynamics
                           8.7.1.2. Regulatory framework/ reimbursement structure
                           8.7.1.3. Competitive scenario
                           8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.2. Saudi Arabia
                           8.7.2.1. Key country dynamics
                           8.7.2.2. Regulatory framework/ reimbursement structure
                           8.7.2.3. Competitive scenario
                           8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.3. UAE
                           8.7.3.1. Key country dynamics
                           8.7.3.2. Regulatory framework/ reimbursement structure
                           8.7.3.3. Competitive scenario
                           8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                       8.7.4. Kuwait
                           8.7.4.1. Key country dynamics
                           8.7.4.2. Regulatory framework/ reimbursement structure
                           8.7.4.3. Competitive scenario
                           8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
                   9.1. Market Participant Categorization
                   9.2. Recent Developments & Impact Analysis by Key Market Participants
                   9.3. Company Market Share Analysis, 2024
                   9.4. Key Company Profiles
                       9.4.1. Novo Nordisk A/S
                           9.4.1.1. Company overview
                           9.4.1.2. Financial performance
                           9.4.1.3. Product benchmarking
                           9.4.1.4. Strategic initiatives
                       9.4.2. Eli Lilly and Company
                           9.4.2.1. Company overview
                           9.4.2.2. Financial performance
                           9.4.2.3. Product benchmarking
                           9.4.2.4. Strategic initiatives
                       9.4.3. Sanofi
                           9.4.3.1. Company overview
                           9.4.3.2. Financial performance
                           9.4.3.3. Product benchmarking
                           9.4.3.4. Strategic initiatives
                       9.4.4. Biocon Ltd
                           9.4.4.1. Company overview
                           9.4.4.2. Financial performance
                           9.4.4.3. Product benchmarking
                           9.4.4.4. Strategic initiatives
                       9.4.5. Wockhardt
                           9.4.5.1. Company overview
                           9.4.5.2. Financial performance
                           9.4.5.3. Product benchmarking
                           9.4.5.4. Strategic initiatives
                       9.4.6. Boehringer Ingelheim International GmbH
                           9.4.6.1. Company overview
                           9.4.6.2. Financial performance
                           9.4.6.3. Product benchmarking
                           9.4.6.4. Strategic initiatives
                       9.4.7. Julphar
                           9.4.7.1. Company overview
                           9.4.7.2. Financial performance
                           9.4.7.3. Product benchmarking
                           9.4.7.4. Strategic initiatives
                       9.4.8. United Laboratories International Holdings Limited
                           9.4.8.1. Company overview
                           9.4.8.2. Financial performance
                           9.4.8.3. Product benchmarking
                           9.4.8.4. Strategic initiatives
                       9.4.9. Tonghua Dongbao Pharmaceutical Co. Ltd.
                           9.4.9.1. Company overview
                           9.4.9.2. Financial performance
                           9.4.9.3. Product benchmarking
                           9.4.9.4. Strategic initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. List of secondary sources
Table 4. List of Abbreviations
Table 5. North America insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 6. North America insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 7. North America insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 8. North America insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 9. U.S. insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 10. U.S. insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 11. U.S. insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 12. U.S. insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 13. Canada insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 14. Canada insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 15. Canada insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 16. Canada insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 17. Europe insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 18. Europe insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 19. Europe insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 20. Europe insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 21. UK insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 22. UK insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 23. UK insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 24. UK insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 25. Germany insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 26. Germany insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 27. Germany insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 28. Germany insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 29. France insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 30. France insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 31. France insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 32. France insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 33. Italy insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 34. Italy insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 35. Italy insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 36. Italy insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 37. Spain insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 38. Spain insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 39. Spain insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 40. Spain insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 41. Asia Pacific insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 42. Asia Pacific insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 43. Asia Pacific insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 44. Asia Pacific insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 45. Japan insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 46. Japan insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 47. Japan insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 48. Japan insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 49. China insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 50. China insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 51. China insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 52. China insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 53. India insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 54. India insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 55. India insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 56. India insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 57. Australia insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 58. Australia insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 59. Australia insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 60. Australia insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 61. South Korea insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 62. South Korea insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 63. South Korea insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 64. South Korea insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 65. Latin America insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 66. Latin America insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 67. Latin America insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 68. Latin America insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 69. Brazil insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 70. Brazil insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 71. Brazil insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 72. Brazil insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 73. Mexico insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 74. Mexico insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 75. Mexico insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 76. Mexico insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 77. Argentina insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 78. Argentina insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 79. Argentina insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 80. Argentina insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 81. MEA insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 82. MEA insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 83. MEA insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 84. MEA insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 85. South Africa insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 86. South Africa insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 87. South Africa insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 88. South Africa insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 90. Saudi Arabia insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 91. Saudi Arabia insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 92. Saudi Arabia insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 93. UAE insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 94. UAE insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 95. UAE insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 96. UAE insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD) Million
Table 97. List of key distributors

List of Figures

Fig. 1 Market research approaches
Fig. 2 Value chain-based sizing & forecasting
Fig. 3 Market formulation & validation
Fig. 4 Insulin market segmentation
Fig. 5 Market driver analysis (current & future impact)
Fig. 6 Market restraint analysis (current & future impact)
Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 8 Porter’s five forces analysis
Fig. 9 Global insulin market: Product type outlook and key takeaways
Fig. 10 Global insulin market: Product type movement analysis
Fig. 11 Rapid-acting insulin market estimates and forecast, 2018–2030 (USD Million)
Fig. 12 Long-acting insulin market estimates and forecast, 2018–2030 (USD Million)
Fig. 13 Combination Insulin market estimates and forecast, 2018–2030 (USD Million)
Fig. 14 Biosimilar market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Others market estimates and forecast, estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Global insulin market: type outlook and key takeaways
Fig. 17 Global insulin market: Type movement analysis
Fig. 18 Human insulin market estimates and forecast, 2018–2030 (USD Million)
Fig. 19 Insulin Analog market estimates and forecast, 2018–2030 (USD Million)
Fig. 20 Global Insulin market: Application type outlook and key takeaways
Fig. 21 Global insulin market: Application type movement analysis
Fig. 22 Type 1 diabetes mellitus market estimates and forecast, 2018–2030
Fig. 23 Type 2 diabetes mellitus market estimates and forecast, 2018–2030
Fig. 24 Global insulin market: Distribution channel outlook and key takeaways
Fig. 25 Global insulin market: Distribution channel movement analysis
Fig. 26 Hospital pharmacy market estimates and forecast, 2018–2030 (USD Million)
Fig. 27 Retail pharmacy market estimates and forecast, 2018–2030 (USD Million)
Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 North America Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 US Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Canada Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Mexico Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Europe Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 UK Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Germany Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 France Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Italy Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Spain Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Denmark Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Sweden Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Norway Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Japan Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 China Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 India Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Australia Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Thailand Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Latin America Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Argentina Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 MEA Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 South Africa Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 UAE Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Kuwait Insulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 List of key emerging company’s/disruptors/innovators